List of SBIR/STTR awards granted to LUCEOME BIOTECHNOLOGIES, L.L.C.
LUCEOME BIOTECHNOLOGIES, L.L.C.Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to LUCEOME BIOTECHNOLOGIES, L.L.C. in March, 2019 for $225,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI145502-01 | Phase I | 225,000 | March 11, 2019 | |||||||
A SBIR Phase II contract was awarded to LUCEOME BIOTECHNOLOGIES, L.L.C. in December, 2019 for $957,654.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AI150237-01 | Phase II | 957,654 | December 16, 2019 | |||||||
A SBIR Phase I contract was awarded to LUCEOME BIOTECHNOLOGIES, L.L.C. in April, 2022 for $240,429.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43GM146510-01 | Phase I | 240,429 | April 1, 2022 | |||||||
A SBIR Phase II contract was awarded to LUCEOME BIOTECHNOLOGIES, L.L.C. in January, 2016 for $1,496,363.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44GM109740-02 | Phase II | 1,496,363 | January 15, 2016 | |||||||
A SBIR Phase II contract was awarded to LUCEOME BIOTECHNOLOGIES, L.L.C. in February, 2017 for $1,408,440.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44TR001916-01 | Phase II | 1,408,440 | February 1, 2017 | |||||||
A SBIR Phase I contract was awarded to LUCEOME BIOTECHNOLOGIES, L.L.C. for $274,561.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM109726-01 | Phase I | 274,561 | ||||||||
A SBIR Phase II contract was awarded to LUCEOME BIOTECHNOLOGIES, L.L.C. for $1,705,661.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44GM087807-02 | Phase II | 1,705,661 | ||||||||
A SBIR Phase I contract was awarded to LUCEOME BIOTECHNOLOGIES, L.L.C. for $239,923.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM109740-01A1 | Phase I | 239,923 | ||||||||
A SBIR Phase I contract was awarded to LUCEOME BIOTECHNOLOGIES, L.L.C. for $224,251.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM110911-01 | Phase I | 224,251 | ||||||||
A SBIR Phase I contract was awarded to LUCEOME BIOTECHNOLOGIES, L.L.C. for $135,886.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM087807-01A1 | Phase I | 135,886 | ||||||||
A SBIR Phase I contract was awarded to LUCEOME BIOTECHNOLOGIES, L.L.C. for $287,417.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM096538-01A1 | Phase I | 287,417 | ||||||||
A SBIR Phase II contract was awarded to LUCEOME BIOTECHNOLOGIES, L.L.C. in March, 2023 for $1,000,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44AI145502-02 | Phase II | 1,000,000 | March 1, 2023 |
